CytomX Therapeutics, Inc.

Organization

WASHINGTON, DC, US

Ticker Symbols

NASDAQ:CTMX

Organizations

Please log in for detailed analytics

Patents Grantslast 30 patents

Information Patent Grant
Activatable anti-VEGF scFv
- Patent number 12,209,120
- Issue date Jan 28, 2025
- The Regents of the University of California
- Patrick Sean Daugherty
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Protease-resistant systems for polypeptide display and methods of m...
- Patent number 12,139,816
- Issue date Nov 12, 2024
- CytomX Therapeutics, Inc.
- Sherry Lynn La Porte
- C40 - COMBINATORIAL CHEMISTRY
Information Patent Grant
Method of using an anti-epidermal growth factor receptor (EGFR) act...
- Patent number 12,139,543
- Issue date Nov 12, 2024
- CytomX Therapeutics, Inc.
- Henry Bernard Lowman
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Activatable cytokine constructs and related compositions and methods
- Patent number 12,091,442
- Issue date Sep 17, 2024
- CytomX Therapeutics, Inc.
- Sayantan Mitra
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Matrix metalloprotease-cleavable and serine or cysteine protease-cl...
- Patent number 12,049,505
- Issue date Jul 30, 2024
- CytomX Therapeutics, Inc.
- Olga Vasiljeva
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Compositions and methods for conjugating activatable antibodies
- Patent number 11,992,528
- Issue date May 28, 2024
- CytomX Therapeutics, Inc.
- Henry Bernard Lowman
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Anti-CD40 antibodies and uses thereof
- Patent number 11,952,427
- Issue date Apr 9, 2024
- Bristol-Myers Squibb Company
- Bryan C. Barnhart
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Activatable antibodies that bind epidermal growth factor receptor a...
- Patent number 11,890,354
- Issue date Feb 6, 2024
- CytomX Therapeutics, Inc.
- Henry Bernard Lowman
- G01 - MEASURING TESTING
Information Patent Grant
Matriptase and u-plasminogen activator substrates and other cleavab...
- Patent number 11,884,746
- Issue date Jan 30, 2024
- CytomX Therapeutics, Inc.
- Stephen James Moore
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Compositions and methods for detecting protease activity in biologi...
- Patent number 11,867,695
- Issue date Jan 9, 2024
- CytomX Therapeutics, Inc.
- Olga Vasiljeva
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Antibodies, activatable antibodies, bispecific antibodies, and bisp...
- Patent number 11,859,010
- Issue date Jan 2, 2024
- CytomX Therapeutics, Inc.
- Leila Marie Boustany
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Matrix metalloproteinase substrates and other cleavable moieties an...
- Patent number 11,814,410
- Issue date Nov 14, 2023
- CytomX Therapeutics, Inc.
- Stephen James Moore
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Bispecific anti-CD3 antibodies, bispecific activatable anti-CD3 ant...
- Patent number 11,802,158
- Issue date Oct 31, 2023
- Cytomx Therapeutics, Inc.
- Bryan Allen Irving
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Anti-CD166 antibodies, activatable anti-CD166 antibodies, and metho...
- Patent number 11,753,466
- Issue date Sep 12, 2023
- CytomX Therapeutics, Inc.
- James William West
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Masked activatable interferon constructs
- Patent number 11,667,687
- Issue date Jun 6, 2023
- CytomX Therapeutics, Inc.
- Sayantan Mitra
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Matrix metalloprotease-cleavable and serine protease-cleavable subs...
- Patent number 11,548,944
- Issue date Jan 10, 2023
- CytomX Therapeutics, Inc.
- Stephen James Moore
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Matrix metalloprotease-cleavable and serine protease-cleavable subs...
- Patent number 11,548,943
- Issue date Jan 10, 2023
- CytomX Therapeutics, Inc.
- Stephen James Moore
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Antibodies, activatable antibodies, bispecific antibodies, and bisp...
- Patent number 11,472,889
- Issue date Oct 18, 2022
- CYTOMX THERAPEUTICS, INC.
- Leila Marie Boustany
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Matrix metalloprotease-cleavable and serine protease-cleavable subs...
- Patent number 11,472,875
- Issue date Oct 18, 2022
- CytomX Therapeutics, Inc.
- Stephen James Moore
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Activatable cytokine constructs and related compositions and methods
- Patent number 11,365,233
- Issue date Jun 21, 2022
- CytomX Therapeutics, Inc.
- Sayantan Mitra
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Anti-CD40 antibodies and uses thereof
- Patent number 11,306,149
- Issue date Apr 19, 2022
- Bristol-Myers Squibb Company
- Bryan C. Barnhart
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Anti-CD71 antibodies, activatable anti-CD71 antibodies, and methods...
- Patent number 11,267,896
- Issue date Mar 8, 2022
- CytomX Therapeutics, Inc.
- Jason Gary Sagert
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Anti-CD166 antibodies and uses thereof
- Patent number 11,220,544
- Issue date Jan 11, 2022
- CytomX Therapeutics, Inc.
- Luc Roland Desnoyers
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Protease-resistant systems for polypeptide display and methods of m...
- Patent number 11,198,864
- Issue date Dec 14, 2021
- CytomX Therapeutics, Inc.
- Sherry Lynn La Porte
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Method of treating or delaying progression of an epidermal growth f...
- Patent number 11,180,562
- Issue date Nov 23, 2021
- CytomX Therapeutics, Inc.
- Henry Bernard Lowman
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Anti-PDL1 antibodies, activatable anti-PDL1 antibodies, and methods...
- Patent number 11,174,316
- Issue date Nov 16, 2021
- CytomX Therapeutics, Inc.
- James William West
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Activatable anti-PDL1 antibodies, and methods of use thereof
- Patent number 11,168,144
- Issue date Nov 9, 2021
- CytomX Therapeutics, Inc.
- Rachel Humphrey
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Multispecific antibodies, multispecific activatable antibodies and...
- Patent number 11,161,906
- Issue date Nov 2, 2021
- CytomX Therapeutics, Inc.
- Henry Bernard Lowman
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Activatable anti-CTLA-4 antibodies and uses thereof
- Patent number 11,117,968
- Issue date Sep 14, 2021
- Bristol-Myers Squibb Company
- Kimberly Ann Tipton
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Matrix metalloprotease-cleavable and serine protease-cleavable subs...
- Patent number 11,046,759
- Issue date Jun 29, 2021
- CytomX Therapeutics, Inc.
- Stephen James Moore
- C07 - ORGANIC CHEMISTRY

Please log in for detailed analytics

Patents Applicationslast 30 patents

Information Patent Application
PROTEASE-RESISTANT SYSTEMS FOR POLYPEPTIDE DISPLAY AND METHODS OF M...
- Publication number 20250034755
- Publication date Jan 30, 2025
- CytomX Therapeutics, Inc.
- Sherry Lynn La Porte
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
ACTIVATABLE CYTOKINE CONSTRUCTS AND COMBINATION METHODS
- Publication number 20250026801
- Publication date Jan 23, 2025
- CytomX Therapeutics, Inc.
- Alexey Yevgenyevich Berezhnoy
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
MATRIX METALLOPROTEASE-CLEAVABLE AND SERINE OR CYSTEINE PROTEASE-CL...
- Publication number 20250011439
- Publication date Jan 9, 2025
- CytomX Therapeutics, Inc.
- Olga VASILJEVA
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
ACTIVATABLE CYTOKINE CONSTRUCTS AND RELATED COMPOSITIONS AND METHODS
- Publication number 20240400630
- Publication date Dec 5, 2024
- CytomX Therapeutics, Inc.
- Na CAI
- C07 - ORGANIC CHEMISTRY
Information Patent Application
TRIMERIC ACTIVATABLE CYTOKINE CONSTRUCTS AND RELATED COMPOSITIONS A...
- Publication number 20240398920
- Publication date Dec 5, 2024
- CytomX Therapeutics, Inc.
- Erwan LE SCOLAN
- C07 - ORGANIC CHEMISTRY
Information Patent Application
ACTIVATABLE ANTIBODIES THAT BIND EPIDERMAL GROWTH FACTOR RECEPTOR A...
- Publication number 20240398998
- Publication date Dec 5, 2024
- CytomX Therapeutics, Inc.
- Henry Bernard Lowman
- G01 - MEASURING TESTING
Information Patent Application
METHOD FOR DETERMINING PROTEASE ACTIVITY IN A BIOLOGICAL SAMPLE
- Publication number 20240384323
- Publication date Nov 21, 2024
- CytomX Therapeutics, Inc.
- Olga VASILJEVA
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
COMPOSITIONS AND METHODS FOR DETECTING PROTEASE ACTIVITY IN BIOLOGI...
- Publication number 20240337658
- Publication date Oct 10, 2024
- CytomX Therapeutics, Inc.
- Olga VASILJEVA
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
MATRIX METALLOPROTEASE-CLEAVABLE AND SERINE OR CYSTEINE PROTEASE-CL...
- Publication number 20240239904
- Publication date Jul 18, 2024
- CytomX Therapeutics, Inc.
- Olga VASILJEVA
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
MODIFIED ANTIBODY COMPOSITIONS, METHODS OF MAKING AND USING THEREOF
- Publication number 20240228603
- Publication date Jul 11, 2024
- CytomX Therapeutics, Inc.
- Nancy Elizabeth Stagliano
- G01 - MEASURING TESTING
Information Patent Application
MATRIPTASE AND U-PLASMINOGEN ACTIVATOR SUBSTRATES AND OTHER CLEAVAB...
- Publication number 20240150402
- Publication date May 9, 2024
- CytomX Therapeutics, Inc.
- Stephen James Moore
- C07 - ORGANIC CHEMISTRY
Information Patent Application
ANTIBODIES, ACTIVATABLE ANTIBODIES, BISPECIFIC ANTIBODIES, AND BISP...
- Publication number 20240150492
- Publication date May 9, 2024
- CytomX Therapeutics, Inc.
- Leila Marie Boustany
- C07 - ORGANIC CHEMISTRY
Information Patent Application
MATRIX METALLOPROTEINASE SUBSTRATES AND OTHER CLEAVABLE MOIETIES AN...
- Publication number 20240150478
- Publication date May 9, 2024
- CytomX Therapeutics, Inc.
- Stephen James Moore
- C07 - ORGANIC CHEMISTRY
Information Patent Application
MASKED ACTIVATABLE CYTOKINE CONSTRUCTS AND RELATED COMPOSITIONS AND...
- Publication number 20240124546
- Publication date Apr 18, 2024
- CytomX Therapeutics, Inc.
- Sayantan MITRA
- C07 - ORGANIC CHEMISTRY
Information Patent Application
MATRIX METALLOPROTEINASE SUBSTRATES AND OTHER CLEAVABLE MOIETIES AN...
- Publication number 20240084022
- Publication date Mar 14, 2024
- CytomX Therapeutics, Inc.
- Stephen James Moore
- C07 - ORGANIC CHEMISTRY
Information Patent Application
BISPECIFIC ANTI-CD3 ANTIBODIES, BISPECIFIC ACTIVATABLE ANTI-CD3 ANT...
- Publication number 20240084010
- Publication date Mar 14, 2024
- CytomX Therapeutics, Inc.
- Bryan Allen Irving
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ANTI-CD166 ANTIBODIES, ACTIVATABLE ANTI-CD166 ANTIBODIES, AND METHO...
- Publication number 20240076374
- Publication date Mar 7, 2024
- CytomX Therapeutics, Inc.
- James William West
- C07 - ORGANIC CHEMISTRY
Information Patent Application
MATRIX METALLOPROTEASE-CLEAVABLE AND SERINE PROTEASE-CLEAVABLE SUBS...
- Publication number 20230212283
- Publication date Jul 6, 2023
- CytomX Therapeutics, Inc.
- Stephen James Moore
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ACTIVATABLE CYTOKINE CONSTRUCTS AND COMBINATION METHODS
- Publication number 20230192798
- Publication date Jun 22, 2023
- CytomX Therapeutics, Inc.
- Alexey Yevgenyevich Berezhnoy
- C07 - ORGANIC CHEMISTRY
Information Patent Application
PROPROTEINS AND METHODS OF USE THEREOF
- Publication number 20230183308
- Publication date Jun 15, 2023
- CytomX Therapeutics, Inc.
- Nancy E. Stagliano
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ACTIVATABLE POLYPEPTIDE COMPLEX
- Publication number 20230183382
- Publication date Jun 15, 2023
- CytomX Therapeutics, Inc.
- Leila M. BOUSTANY
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ACTIVATABLE POLYPEPTIDE COMPLEX
- Publication number 20230174995
- Publication date Jun 8, 2023
- CytomX Therapeutics, Inc.
- Leila M. BOUSTANY
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
AURISTATIN-RELATED COMPOUNDS, CONJUGATED AURISTATIN-RELATED COMPOUN...
- Publication number 20230071763
- Publication date Mar 9, 2023
- CytomX Therapeutics, Inc.
- Siew Schleyer
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ANTI-SLC34A2 ANTIBODIES, ANTIBODY DRUG CONJUGATES, AND METHODS OF U...
- Publication number 20230073692
- Publication date Mar 9, 2023
- CytomX Therapeutics, Inc.
- Dowdy Jackson
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ANTI-PSMA ANTIBODIES, ANTIBODY DRUG CONJUGATES, AND METHODS OF USE...
- Publication number 20230059690
- Publication date Feb 23, 2023
- CytomX Therapeutics, Inc.
- Rene Hubert
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
SINGLE-AND MULTI-CHAIN POLYPEPTIDES THAT BIND SPECIFICALLY TO CD3 E...
- Publication number 20230057263
- Publication date Feb 23, 2023
- CytomX Therapeutics, Inc.
- Christopher KEMBALL
- C07 - ORGANIC CHEMISTRY
Information Patent Application
ANTIBODIES, ACTIVATABLE ANTIBODIES, BISPECIFIC ANTIBODIES, AND BISP...
- Publication number 20230050083
- Publication date Feb 16, 2023
- CytomX Therapeutics, Inc.
- Leila Marie Boustany
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
PROPROTEINS AND METHODS OF USE THEREOF
- Publication number 20230035290
- Publication date Feb 2, 2023
- CytomX Therapeutics, Inc.
- Nancy E. Stagliano
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
MATRIX METALLOPROTEASE-CLEAVABLE AND SERINE PROTEASE-CLEAVABLE SUBS...
- Publication number 20230021301
- Publication date Jan 19, 2023
- CytomX Therapeutics, Inc.
- Stephen James Moore
- C07 - ORGANIC CHEMISTRY
Information Patent Application
MATRIPTASE AND U-PLASMINOGEN ACTIVATOR SUBSTRATES AND OTHER CLEAVAB...
- Publication number 20220411470
- Publication date Dec 29, 2022
- CytomX Therapeutics, Inc.
- Stephen James Moore
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Please log in for detailed analytics

Trademarklast 30 trademarks

Information Trademark
98292514 - PROBODY
- Serial number 98292514
- Filing date Nov 30, 2023
- CytomX Therapeutics, Inc.
- 5 - Pharmaceutical and veterinary preparations
Information Trademark
97161896 - XPONDRA
- Serial number 97161896
- Filing date Dec 8, 2021
- CytomX Therapeutics, Inc.
- 5 - Pharmaceutical and veterinary preparations
Information Trademark
97161889 - XPONDRE
- Serial number 97161889
- Filing date Dec 8, 2021
- CytomX Therapeutics, Inc.
- 5 - Pharmaceutical and veterinary preparations
Information Trademark
88296649 - IOVONDA
- Serial number 88296649
- Filing date Feb 11, 2019
- CytomX Therapeutics, Inc.
- 5 - Pharmaceutical and veterinary preparations
Information Trademark
88237374 - XPONDRA
- Serial number 88237374
- Filing date Dec 20, 2018
- CytomX Therapeutics, Inc.
- 5 - Pharmaceutical and veterinary preparations
Information Trademark
88237393 - XPONDRE
- Serial number 88237393
- Filing date Dec 20, 2018
- CytomX Therapeutics, Inc.
- 5 - Pharmaceutical and veterinary preparations
Information Trademark
88237412 - IOVANDA
- Serial number 88237412
- Filing date Dec 20, 2018
- CytomX Therapeutics, Inc.
- 5 - Pharmaceutical and veterinary preparations
Information Trademark
87978555
- Serial number 87978555
- Registration number 5603397
- Filing date Jun 20, 2017
- CytomX Therapeutics, Inc.
- 5 - Pharmaceutical and veterinary preparations
Information Trademark
87497304
- Serial number 87497304
- Filing date Jun 20, 2017
- CytomX Therapeutics, Inc.
- 1 - Chemicals used in industry, science and photography, as well as in agriculture, horticulture and forestry
Information Trademark
87421067 - CYTOMX
- Serial number 87421067
- Filing date Apr 21, 2017
- CytomX Therapeutics, Inc.
- 1 - Chemicals used in industry, science and photography, as well as in agriculture, horticulture and forestry
Information Trademark
87978592 - CYTOMX
- Serial number 87978592
- Registration number 5603402
- Filing date Apr 21, 2017
- CytomX Therapeutics, Inc.
- 5 - Pharmaceutical and veterinary preparations
Information Trademark
86739853 - IHZ
- Serial number 86739853
- Filing date Aug 27, 2015
- CytomX Therapeutics, Inc.
- 1 - Chemicals used in industry, science and photography, as well as in agriculture, horticulture and forestry
Information Trademark
86711505 - PROBODY
- Serial number 86711505
- Filing date Jul 31, 2015
- CytomX Therapeutics, Inc.
- 1 - Chemicals used in industry, science and photography, as well as in agriculture, horticulture and forestry
Information Trademark
86983300 - PROBODY
- Serial number 86983300
- Registration number 5355828
- Filing date Jul 31, 2015
- CytomX Therapeutics, Inc.
- 5 - Pharmaceutical and veterinary preparations
Information Trademark
77744555 - PROBODY
- Serial number 77744555
- Filing date May 26, 2009
- CytomX Therapeutics, LLC
- 1 - Chemicals used in industry, science and photography, as well as in agriculture, horticulture and forestry

NIH Research Projectlast 12 months

processing...

Count: 2

Research Projects

Information Research Project
Development of Probodies: A Novel Class of Therapeutic Antibodies C...
- Application id 7671716
- Award notice date May 27, 2009
Information Research Project
Discovery of a Novel, Integrated Combination Peptide Therapeutic Ta...
- Application id 7481536
- Award notice date May 30, 2008

CytomX Therapeutics, Inc.

Organization

Ticker Symbols

Patents Grantslast 30 patents

Activatable anti-VEGF scFv

Protease-resistant systems for polypeptide display and methods of m...

Method of using an anti-epidermal growth factor receptor (EGFR) act...

Activatable cytokine constructs and related compositions and methods

Matrix metalloprotease-cleavable and serine or cysteine protease-cl...

Compositions and methods for conjugating activatable antibodies

Anti-CD40 antibodies and uses thereof

Activatable antibodies that bind epidermal growth factor receptor a...

Matriptase and u-plasminogen activator substrates and other cleavab...

Compositions and methods for detecting protease activity in biologi...

Antibodies, activatable antibodies, bispecific antibodies, and bisp...

Matrix metalloproteinase substrates and other cleavable moieties an...

Bispecific anti-CD3 antibodies, bispecific activatable anti-CD3 ant...

Anti-CD166 antibodies, activatable anti-CD166 antibodies, and metho...

Masked activatable interferon constructs

Matrix metalloprotease-cleavable and serine protease-cleavable subs...

Matrix metalloprotease-cleavable and serine protease-cleavable subs...

Antibodies, activatable antibodies, bispecific antibodies, and bisp...

Matrix metalloprotease-cleavable and serine protease-cleavable subs...

Activatable cytokine constructs and related compositions and methods

Anti-CD40 antibodies and uses thereof

Anti-CD71 antibodies, activatable anti-CD71 antibodies, and methods...

Anti-CD166 antibodies and uses thereof

Protease-resistant systems for polypeptide display and methods of m...

Method of treating or delaying progression of an epidermal growth f...

Anti-PDL1 antibodies, activatable anti-PDL1 antibodies, and methods...

Activatable anti-PDL1 antibodies, and methods of use thereof

Multispecific antibodies, multispecific activatable antibodies and...

Activatable anti-CTLA-4 antibodies and uses thereof

Matrix metalloprotease-cleavable and serine protease-cleavable subs...

Patents Applicationslast 30 patents

PROTEASE-RESISTANT SYSTEMS FOR POLYPEPTIDE DISPLAY AND METHODS OF M...

ACTIVATABLE CYTOKINE CONSTRUCTS AND COMBINATION METHODS

MATRIX METALLOPROTEASE-CLEAVABLE AND SERINE OR CYSTEINE PROTEASE-CL...

ACTIVATABLE CYTOKINE CONSTRUCTS AND RELATED COMPOSITIONS AND METHODS

TRIMERIC ACTIVATABLE CYTOKINE CONSTRUCTS AND RELATED COMPOSITIONS A...

ACTIVATABLE ANTIBODIES THAT BIND EPIDERMAL GROWTH FACTOR RECEPTOR A...

METHOD FOR DETERMINING PROTEASE ACTIVITY IN A BIOLOGICAL SAMPLE

COMPOSITIONS AND METHODS FOR DETECTING PROTEASE ACTIVITY IN BIOLOGI...

MATRIX METALLOPROTEASE-CLEAVABLE AND SERINE OR CYSTEINE PROTEASE-CL...

MODIFIED ANTIBODY COMPOSITIONS, METHODS OF MAKING AND USING THEREOF

MATRIPTASE AND U-PLASMINOGEN ACTIVATOR SUBSTRATES AND OTHER CLEAVAB...

ANTIBODIES, ACTIVATABLE ANTIBODIES, BISPECIFIC ANTIBODIES, AND BISP...

MATRIX METALLOPROTEINASE SUBSTRATES AND OTHER CLEAVABLE MOIETIES AN...

MASKED ACTIVATABLE CYTOKINE CONSTRUCTS AND RELATED COMPOSITIONS AND...

MATRIX METALLOPROTEINASE SUBSTRATES AND OTHER CLEAVABLE MOIETIES AN...

BISPECIFIC ANTI-CD3 ANTIBODIES, BISPECIFIC ACTIVATABLE ANTI-CD3 ANT...

ANTI-CD166 ANTIBODIES, ACTIVATABLE ANTI-CD166 ANTIBODIES, AND METHO...

MATRIX METALLOPROTEASE-CLEAVABLE AND SERINE PROTEASE-CLEAVABLE SUBS...

ACTIVATABLE CYTOKINE CONSTRUCTS AND COMBINATION METHODS

PROPROTEINS AND METHODS OF USE THEREOF

ACTIVATABLE POLYPEPTIDE COMPLEX

ACTIVATABLE POLYPEPTIDE COMPLEX

AURISTATIN-RELATED COMPOUNDS, CONJUGATED AURISTATIN-RELATED COMPOUN...

ANTI-SLC34A2 ANTIBODIES, ANTIBODY DRUG CONJUGATES, AND METHODS OF U...

ANTI-PSMA ANTIBODIES, ANTIBODY DRUG CONJUGATES, AND METHODS OF USE...

SINGLE-AND MULTI-CHAIN POLYPEPTIDES THAT BIND SPECIFICALLY TO CD3 E...

ANTIBODIES, ACTIVATABLE ANTIBODIES, BISPECIFIC ANTIBODIES, AND BISP...

PROPROTEINS AND METHODS OF USE THEREOF

MATRIX METALLOPROTEASE-CLEAVABLE AND SERINE PROTEASE-CLEAVABLE SUBS...

MATRIPTASE AND U-PLASMINOGEN ACTIVATOR SUBSTRATES AND OTHER CLEAVAB...

Trademarklast 30 trademarks

98292514 - PROBODY

97161896 - XPONDRA

97161889 - XPONDRE

88296649 - IOVONDA

88237374 - XPONDRA

88237393 - XPONDRE

88237412 - IOVANDA

87978555

87497304

87421067 - CYTOMX

87978592 - CYTOMX

86739853 - IHZ

86711505 - PROBODY

86983300 - PROBODY